缓激肽B2受体拮抗剂依卡替班治疗急性遗传性血管性水肿的新型药物疗法。 - Suppr

Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.

作者信息

Bas M, Bier H, Greve J, Kojda G, Hoffmann T K

机构信息

Klinik für Hals-, Nasen- und Ohrenheilkunde, Universitätsklinikum Düsseldorf, Moorenstr. 5, D-40225 Düsseldorf, Germany.

出版信息

Allergy. 2006 Dec;61(12):1490-2. doi: 10.1111/j.1398-9995.2006.01197.x.

DOI:10.1111/j.1398-9995.2006.01197.x

PMID:17073887

Abstract

摘要

相似文献

Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.

Allergy. 2006 Dec;61(12):1490-2. doi: 10.1111/j.1398-9995.2006.01197.x.

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).

J Allergy Clin Immunol. 2007 Jun;119(6):1497-503. doi: 10.1016/j.jaci.2007.02.012. Epub 2007 Apr 5.

Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.

Ann Allergy Asthma Immunol. 2012 Jun;108(6):460-1. doi: 10.1016/j.anai.2012.03.013. Epub 2012 Apr 10.

Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.

Expert Opin Pharmacother. 2012 Oct;13(15):2233-47. doi: 10.1517/14656566.2012.723692. Epub 2012 Sep 13.

Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.

Int J Dermatol. 2011 Oct;50(10):1294-5. doi: 10.1111/j.1365-4632.2011.05051.x.

Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.

Ann Allergy Asthma Immunol. 2011 Dec;107(6):529-37. doi: 10.1016/j.anai.2011.08.015. Epub 2011 Oct 5.

Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant.

J Dtsch Dermatol Ges. 2010 Apr;8(4):272-4. doi: 10.1111/j.1610-0387.2009.07215.x. Epub 2009 Sep 16.

Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant.

J Am Acad Dermatol. 2010 Nov;63(5):913-4. doi: 10.1016/j.jaad.2010.03.023. Epub 2010 Jun 15.

Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.

Ann Emerg Med. 2010 Sep;56(3):278-82. doi: 10.1016/j.annemergmed.2010.03.032. Epub 2010 May 5.

Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.

Allergy. 2012 Aug;67(8):1074-7. doi: 10.1111/j.1398-9995.2012.02853.x. Epub 2012 Jun 12.

引用本文的文献

Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B receptor antagonism.

J Mol Med (Berl). 2022 Apr;100(4):613-627. doi: 10.1007/s00109-022-02182-7. Epub 2022 Mar 5.

WAO Guideline for the Management of Hereditary Angioedema.

World Allergy Organ J. 2012 Dec;5(12):182-99. doi: 10.1097/WOX.0b013e318279affa.

An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.

Core Evid. 2012;7:105-14. doi: 10.2147/CE.S24743. Epub 2012 Sep 27.

[Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options].

Anaesthesist. 2011 Dec;60(12):1141-5. doi: 10.1007/s00101-010-1798-3. Epub 2010 Oct 6.

Management of acute attacks of hereditary angioedema: potential role of icatibant.

Vasc Health Risk Manag. 2010 Sep 7;6:795-802. doi: 10.2147/vhrm.s4332.

Management of upper airway edema caused by hereditary angioedema.

Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):19. doi: 10.1186/1710-1492-6-19.

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.

Br J Pharmacol. 2008 Mar;153(5):947-55. doi: 10.1038/sj.bjp.0707641. Epub 2007 Dec 17.

C1-inhibitor deficiencies (hereditary angioedema): where are we with therapies?

Curr Allergy Asthma Rep. 2007 Jul;7(4):264-9. doi: 10.1007/s11882-007-0039-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.

作者信息

Bas M, Bier H, Greve J, Kojda G, Hoffmann T K

机构信息

Klinik für Hals-, Nasen- und Ohrenheilkunde, Universitätsklinikum Düsseldorf, Moorenstr. 5, D-40225 Düsseldorf, Germany.

出版信息

Allergy. 2006 Dec;61(12):1490-2. doi: 10.1111/j.1398-9995.2006.01197.x.

DOI:10.1111/j.1398-9995.2006.01197.x

PMID:17073887

Abstract

摘要

相似文献

Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.

Allergy. 2006 Dec;61(12):1490-2. doi: 10.1111/j.1398-9995.2006.01197.x.

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).

J Allergy Clin Immunol. 2007 Jun;119(6):1497-503. doi: 10.1016/j.jaci.2007.02.012. Epub 2007 Apr 5.

Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant.

Ann Allergy Asthma Immunol. 2012 Jun;108(6):460-1. doi: 10.1016/j.anai.2012.03.013. Epub 2012 Apr 10.

Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.

Expert Opin Pharmacother. 2012 Oct;13(15):2233-47. doi: 10.1517/14656566.2012.723692. Epub 2012 Sep 13.

Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.

Int J Dermatol. 2011 Oct;50(10):1294-5. doi: 10.1111/j.1365-4632.2011.05051.x.

Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.

Ann Allergy Asthma Immunol. 2011 Dec;107(6):529-37. doi: 10.1016/j.anai.2011.08.015. Epub 2011 Oct 5.

Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant.

J Dtsch Dermatol Ges. 2010 Apr;8(4):272-4. doi: 10.1111/j.1610-0387.2009.07215.x. Epub 2009 Sep 16.

Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant.

J Am Acad Dermatol. 2010 Nov;63(5):913-4. doi: 10.1016/j.jaad.2010.03.023. Epub 2010 Jun 15.

Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.

Ann Emerg Med. 2010 Sep;56(3):278-82. doi: 10.1016/j.annemergmed.2010.03.032. Epub 2010 May 5.

Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.

Allergy. 2012 Aug;67(8):1074-7. doi: 10.1111/j.1398-9995.2012.02853.x. Epub 2012 Jun 12.

引用本文的文献

Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B receptor antagonism.

J Mol Med (Berl). 2022 Apr;100(4):613-627. doi: 10.1007/s00109-022-02182-7. Epub 2022 Mar 5.

WAO Guideline for the Management of Hereditary Angioedema.

World Allergy Organ J. 2012 Dec;5(12):182-99. doi: 10.1097/WOX.0b013e318279affa.

An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.

Core Evid. 2012;7:105-14. doi: 10.2147/CE.S24743. Epub 2012 Sep 27.

[Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options].

Anaesthesist. 2011 Dec;60(12):1141-5. doi: 10.1007/s00101-010-1798-3. Epub 2010 Oct 6.

Management of acute attacks of hereditary angioedema: potential role of icatibant.

Vasc Health Risk Manag. 2010 Sep 7;6:795-802. doi: 10.2147/vhrm.s4332.

Management of upper airway edema caused by hereditary angioedema.

Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):19. doi: 10.1186/1710-1492-6-19.

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.

Br J Pharmacol. 2008 Mar;153(5):947-55. doi: 10.1038/sj.bjp.0707641. Epub 2007 Dec 17.

C1-inhibitor deficiencies (hereditary angioedema): where are we with therapies?

Curr Allergy Asthma Rep. 2007 Jul;7(4):264-9. doi: 10.1007/s11882-007-0039-6.

Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.

作者信息

机构信息

出版信息

相似文献

引用本文的文献